|
|
|||
|
|||
|
|
|||
|
adacel and pharmaceutical |
|||
|
|
|||
|
|||
![]()
|
|||
|
|
|||
|
adacel and pharmaceutical Aventis Submits Application for FDA Licensure of Adacel Vaccine for Preventionof Tetanus, Diphtheria and Pertussis in Adolescents and Adults - Vaccine Leader Looks to Introduce Pertussis Booster in United States - SWIFTWATER, Pa., August 11, 2004 -- Aventis (NYSE:AVE) today announced thesubmission of a Biologics Licensing Application (BLA) to the U.S adacel and pharmaceutical. Food and DrugAdministration (FDA) for marketing approval of Adacel (Tetanus Toxoid and ReducedDiphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed) for prevention oftetanus, diphtheria and pertussis in adolescents and adults aged 11 through64 years adacel and pharmaceutical. The BLA for this candidate vaccine was submitted by Aventis Pasteur,the vaccines business of Aventis. Reported cases of pertussis, commonly known as whooping cough, clearly areon the rise in the U.S adacel and pharmaceutical. In 2002, 9,771 cases were reported to the U.S adacel and pharmaceutical. Centersfor Disease Control and Prevention (CDC), the highest number of such reportsin more than 30 years adacel and pharmaceutical. Preliminary counts of pertussis reports for 2003 exceed10,000, while reporting thus far in 2004 is at an even faster pace adacel and pharmaceutical. However,it is estimated that only 12 percent of pertussis cases are actually reportedand that under-reporting may be greatest among adolescents and adults. "Pertussis continues to be an important public health issue, in part becauseadolescents and adults may not even be aware that they have the disease andthat they can transmit it to vulnerable infants and younger children,"said David R adacel and pharmaceutical. Johnson, MD, MPH, director, scientific and medical affairs, AventisPasteur adacel and pharmaceutical. "We've already had great success in the prevention of tetanusand diphtheria in the U.S adacel and pharmaceutical. and believe that the introduction of a combinationvaccine that also protects against pertussis in adults and adolescents willhelp to counter ongoing transmission of this disease." A vaccine is currently available to protect children against pertussis up to7 years of age adacel and pharmaceutical. The diphtheria, tetanus and pertussis (DTaP) vaccine is generallyadministered in five doses between the ages of 2 months and 6 years of age adacel and pharmaceutical. However, the vaccine does not offer lifelong protection against pertussis, andit is believed that immunity wanes by adolescence adacel and pharmaceutical. While a tetanus and diphtheriabooster immunization is available starting at age 11, a pertussis booster isnot adacel and pharmaceutical. The Adacel tetanus, diphtheria and pertussis vaccine will be referred toas a "Tdap" vaccine; the children's vaccine to prevent these samediseases is known as "DTaP." The pertussis components in Adacel vaccineare based on the acellular pertussis formulation in DAPTACEL(R), Diphtheriaand Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP vaccine),which was successfully introduced by Aventis Pasteur in the U.S adacel and pharmaceutical. in 2002. The regulatory submission for Adacel vaccine is based on results of clinicalstudies involving more than 7,200 clinical trial participants adacel and pharmaceutical. The vaccine hasshown an excellent safety and immunogenicity profile adacel and pharmaceutical. Adacel vaccine is currentlyapproved and marketed in Canada and Germany. Risk of Pertussis Mild pertussis disease is difficult to diagnose because its symptoms are notas distinctive; usually a prolonged cough is present, but without the "whoop."One reason for the incomplete identification of pertussis may be that diagnosisof the disease in adults and adolescents is sometimes difficult because symptomsare often atypical. Although infants and young children may experience mild pertussis disease,it is more often associated with adolescents and adults adacel and pharmaceutical. Even in less severecases, infected adolescents and adults can easily transmit the illness to vulnerableinfants and young children who may experience complications associated withthe disease, such as pneumonia, encephalitis and pertussis- related seizures. "While older patients are often spared the debilitating effects of thedisease, the fact that it may not be properly diagnosed and treated opens thedoor for spreading the disease," said Dr adacel and pharmaceutical. Johnson adacel and pharmaceutical. "Increased outbreaksin this country are an all too common reminder that we need to bring this diseaseunder control." About Tetanus, Diphtheria, Pertussis Diphtheria is a disease caused by exposure to airborne bacteria (Corynebacteriumdiphtheriae) from an infected person and usually affects the tonsils, throat,nose and/or skin adacel and pharmaceutical. It is passed from person to person by droplet transmission,usually by breathing in diphtheria bacteria after an infected person has coughed,sneezed or even laughed adacel and pharmaceutical. It can also be spread by handling used tissues or bydrinking from a glass used by an infected person adacel and pharmaceutical. Symptoms usually appear twoto five days after infection and begin very much like a common cold adacel and pharmaceutical. However,symptoms can progress as a membrane grows and covers anywhere from a small patchto most of the throat, potentially blocking the airway adacel and pharmaceutical. The infection releasesa toxin that can lead to heart failure and paralysis, and if enough toxin isabsorbed into the bloodstream, coma or even death can occur in as little asa week adacel and pharmaceutical. Diphtheria occurs rarely in this country, but is occasionally importedfrom countries where it is endemic adacel and pharmaceutical. Ongoing vaccination to protect against diphtheriacontinues to be recommended. Pertussis, a highly contagious disease of the respiratory tract, is causedby exposure to bacteria (Bordetella pertussis) found in the mouth, nose andthroat of an infected person adacel and pharmaceutical. Pertussis is primarily spread by direct contactwith discharge from the nose or throat of infected individuals adacel and pharmaceutical. Classic, orsevere, pertussis, as defined by the World Health Organization, consists ofat least 21 days of cough illness (with the cough coming in spasms or paroxysms),associated whoops or post-cough vomiting, and culture confirmation adacel and pharmaceutical. Mild pertussisis any laboratory-confirmed pertussis disease that is less than classic disease. Pertussis can occur at any age adacel and pharmaceutical. More than half the cases occur in adolescentsand adults, while the majority of the remaining cases affect children under1 year of age adacel and pharmaceutical. For young children, pertussis disease can result in significantmorbidity, hospitalization, serious long-term complications, and death. About Aventis |
|||
![]()
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
|
|
|||
| aadacel and pharmaceutical addacel and pharmaceutical adaacel and pharmaceutical adaccel and pharmaceutical adaceel and pharmaceutical adacell and pharmaceutical adacel and pharmaceutical adacel aand pharmaceutical adacel annd pharmaceutical adacel andd pharmaceutical adacel and pharmaceutical adacel and ppharmaceutical adacel and phharmaceutical adacel and phaarmaceutical adacel and pharrmaceutical adacel and pharmmaceutical adacel and pharmaaceutical adacel and pharmacceutical adacel and pharmaceeutical adacel and pharmaceuutical adacel and pharmaceuttical adacel and pharmaceutiical adacel and pharmaceuticcal adacel and pharmaceuticaal adacel and pharmaceuticall dacel and pharmaceutical aacel and pharmaceutical adcel and pharmaceutical adael and pharmaceutical adacl and pharmaceutical adace and pharmaceutical adaceland pharmaceutical adacel nd pharmaceutical adacel ad pharmaceutical adacel an pharmaceutical adacel andpharmaceutical adacel and harmaceutical adacel and parmaceutical adacel and phrmaceutical adacel and phamaceutical adacel and pharaceutical adacel and pharmceutical adacel and pharmaeutical adacel and pharmacutical adacel and pharmacetical adacel and pharmaceuical adacel and pharmaceutcal adacel and pharmaceutial adacel and pharmaceuticl adacel and pharmaceutica a dacel and pharmaceutical ad acel and pharmaceutical ada cel and pharmaceutical adac el and pharmaceutical adace l and pharmaceutical adacel and pharmaceutical adacel and pharmaceutical adacel a nd pharmaceutical adacel an d pharmaceutical adacel and pharmaceutical adacel and pharmaceutical adacel and p harmaceutical adacel and ph armaceutical adacel and pha rmaceutical adacel and phar maceutical adacel and pharm aceutical adacel and pharma ceutical adacel and pharmac eutical adacel and pharmace utical adacel and pharmaceu tical adacel and pharmaceut ical adacel and pharmaceuti cal adacel and pharmaceutic al adacel and pharmaceutica l adacel and pharmaceutical daacel and pharmaceutical aadcel and pharmaceutical adcael and pharmaceutical adaecl and pharmaceutical adacle and pharmaceutical adace land pharmaceutical adacela nd pharmaceutical adacel nad pharmaceutical adacel adn pharmaceutical adacel an dpharmaceutical adacel andp harmaceutical adacel and hparmaceutical adacel and pahrmaceutical adacel and phramaceutical adacel and phamraceutical adacel and pharamceutical adacel and pharmcaeutical adacel and pharmaecutical adacel and pharmacuetical adacel and pharmacetuical adacel and pharmaceuitcal adacel and pharmaceutcial adacel and pharmaceutiacl adacel and pharmaceuticla aadacel and pharmaceutical theadacel and pharmaceutical adacel and pharmaceutical | |||
|
|
|||
|
|
|||
|
|
|||
|
Copyright 2005 D-S LTD. |